±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 402  |  »Ø¸´: 1

plu3263

гæ (СÓÐÃûÆø)

[ÇóÖú] ΢Æ×ÇóÖú£º¼±£¡ÇóÖúÒ»¸ö»¯ºÏÎïµÄ΢Æ× 13C NMR ÒÑÓÐ1È˲ÎÓë

̼Æ×Êý¾Ý  ÈܼÁ£ºDMSO
197.7£¬ 169.6£¬ 169.27£¬ 129£¬ 45.5£¬ 44.1£¬ 38.3£¬ 31.3£¬ 29.9£¬ 20.5£¬ 14.0£¬ 10.8£¬
ÁíÍ⺬ÓÐÁ½¸öN
·Ç³£¸Ðл£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

·çÐÐÕß007

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
plu3263: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, лл 2014-07-14 01:25:34
²éѯ½á¹û£º¹²²éµ½4¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼)
1 .     4-Oxocyclopentane-1,2-dicarboxylic acid monoethyl ester p-tosylhydrazone
    ÏàËÆ¶È:50%
Molecules          2012          17          1-14
Facile Preparation of the Tosylhydrazone Derivatives of a Series of Racemic trans-3,4-Substituted Cyclopentanones
Kamal H. Bouhadir, Bilal Abou Aleiwe and Fares A. Fares
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
2 .     4-genzyl-2-sec-butylsulfanyl-5-methyl-1H-imidazole
C15H20N2S     ÏàËÆ¶È:50%
Journal of Heterocyclic Chemistry          2002          39          375-382
Synthesis of imidazoles as novel emivirine and S-DABO analogues
Yasser M. Loksha, Per T. Jørgensen, Erik B. Pedersen, Mahmoud A. El-Badawi, Ahmed A. El-Barbary and Claus Nielsen
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
3 .     4-genzyl-2-sec-butylsulfanyl-5-ethyl-1H-imidazole
C16H22N2S     ÏàËÆ¶È:50%
Journal of Heterocyclic Chemistry          2002          39          375-382
Synthesis of imidazoles as novel emivirine and S-DABO analogues
Yasser M. Loksha, Per T. Jørgensen, Erik B. Pedersen, Mahmoud A. El-Badawi, Ahmed A. El-Barbary and Claus Nielsen
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
4 .     Compound 3
C12H16ClNO2     ÏàËÆ¶È:50%
Magnetic Resonance in Chemistry          2007          45          442-445
Synthesis and spectroscopic characterisation of a combinatorial library based on the fungal natural product 3-chloro-4-hydroxyphenylacetamide (pages 442¨C445)
Rohan A. Davis, Gregory K. Pierens and Peter G. Parsons
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
½Å̤ʵµØ£¬·ÜÁ¦Ò»²«£¬Ô¹¬ÕÛ¹ð
2Â¥2014-07-13 22:25:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ plu3263 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +13 ŬÁ¦·Ü¶·112 2026-04-04 13/650 2026-04-06 07:13 by jj987
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©086000µ÷¼ÁÒ»Ö¾Ô¸Î÷±±Å©ÁÖ320·Ö +3 ÃÀÃÀŮʿ 2026-04-03 3/150 2026-04-05 21:55 by ѧԱ8dgXkO
[¿¼ÑÐ] µ÷¼Á +5 ºÃºÃ¶ÁÊé¡£ 2026-04-01 5/250 2026-04-05 17:54 by liucky
[¿¼ÑÐ] ²ÄÁÏר˶ µ÷¼Á +14 CXN123456 2026-04-03 14/700 2026-04-05 17:18 by Hdyxbekcb
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +8 ÏàÐűػá¹ââÍòÕ 2026-04-05 10/500 2026-04-05 12:19 by Hdyxbekcb
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +11 ¹þ¹þ¹þºðºðºð¹þ 2026-04-02 11/550 2026-04-04 23:37 by ÓÀ×ÖºÅ
[¿¼ÑÐ] 0854Çóµ÷¼Á +4 assdll 2026-04-03 4/200 2026-04-04 22:17 by hemengdong
[¿¼ÑÐ] 0856£¬269·ÖÇóµ÷¼Á +15 ÓÐѧÉϾÍÐÐÇóÇóÁ 2026-03-30 18/900 2026-04-03 16:50 by melodiousnow
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +7 ÏàÐűػá¹ââÍòÕ 2026-04-02 7/350 2026-04-03 16:48 by rzh123456
[¿¼ÑÐ] 11408£¬284·Ö£¬¶þÕ½Õæ³ÏÇóµ÷¼Á +4 12.27 2026-04-02 4/200 2026-04-03 14:14 by dxiaoxin
[¿¼ÑÐ] ±§Ç¸ +5 ÌïºéÓÐ 2026-03-30 5/250 2026-04-03 10:24 by linyelide
[¿¼ÑÐ] 325·Ö»¯Ñ§µ÷¼Á +5 15771691647 2026-04-02 5/250 2026-04-03 09:58 by ChemPharm
[¿¼ÑÐ] Ò»Ö¾Ô¸ÏÃÃÅ´óѧ²ÄÁϹ¤³Ìר˶354ÕÒµ÷¼Á£¡£¡£¡ +8 ±´ß±µ±µ 2026-03-30 8/400 2026-04-03 09:41 by hypershenger
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +11 ¹þ¹þ¹þºðºðºð¹þ 2026-04-01 11/550 2026-04-02 10:52 by lnilvy
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-04-02 4/200 2026-04-02 09:52 by yulian1987
[¿¼ÑÐ] 11408 321·ÖÇóµ÷¼Á +3 huchun12138 2026-03-30 4/200 2026-04-01 22:48 by guanxin1001
[¿¼ÑÐ] 085600 Ò»Ö¾Ô¸9 ×Ü·Ö351 Çóµ÷¼ÁѧУ +7 czhcz 2026-03-31 9/450 2026-04-01 19:24 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Çóµ÷¼Á +4 DADA¹Ö 2026-03-31 4/200 2026-04-01 14:30 by ZXlzxl0425
[¿¼ÑÐ] 326Çóµ÷¼Á +4 áÌáÌ×Ð 2026-03-31 4/200 2026-04-01 09:58 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 269Çóµ÷¼Á +4 ÎÒÏë¶ÁÑÐ11 2026-03-31 4/200 2026-03-31 10:04 by cal0306
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û